Efrat Barbiro‐Michaely

Monitoring EML4-ALK Biomarkers via a Microfluidic Assay for Treatment Efficacy Assessment

Monitoring prognostic biomarkers is essential for evaluating cancer treatment efficacy in real time. Here, we present a rapid, proof-of-concept microfluidic assay for cancer biomarker quantification and functional therapy evaluation. The assay requires only 5 µL of sample, elimin...